[HTML][HTML] Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate

A Kamal, A Elsheaita, M Abdelnabi - World Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Since direct-acting antiviral agents (DAAs) have been introduced into hepatitis C virus
treatment, the sustained viral response (SVR) rate has significantly increased to more than …

Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis

H Wu, K Cai, J Ma, G Chen, Y Dang, H Lu… - Pathology-Research and …, 2019 - Elsevier
Background and aim Extensive research has revealed that microRNAs (miRNAs) play a
principle role in cancer, and miRNAs associated with specific cancers have also been …

干扰素刺激基因15 在消化道恶性肿瘤中的作用及机制研究进展.

江平, 罗晓琴, 翟少倩, 曹成珠… - Journal of Practical …, 2024 - search.ebscohost.com
干扰素刺激基因15 (interferonstimulating gene 15, ISG15) 是一种由Ⅰ 型干扰素诱导的蛋白和
泛素样分子, 属于泛素样蛋白超家族. ISG15 在多种恶性肿瘤中高表达, 且与肿瘤发生 …

Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study

A Kamal, AA Abd Elmoety, YA Rostom… - Clinical and …, 2021 - termedia.pl
Results Data from 52 patients were analyzed. Throughout the 2 years from ablation, 42.3%
of patients experienced tumor recurrence (22 out of 52 patients). In addition, two subjects …

Liver diseases

Q Ou, H Mu, C Zhou, Z Zheng, J Geng - Clinical Molecular Diagnostics, 2021 - Springer
The liver, with four lobes of unequal size and shape, is a reddish-brown, wedge-shaped
organ with dual blood supply. As the heaviest parenchymatous organ in the human body, it …

Liver Diseases 33

Q Ou, H Mu, C Zhou, Z Zheng… - Clinical Molecular …, 2021 - books.google.com
Viral hepatitis, a severe international public health problem, is caused by hepatitis viruses
which are a group of viruses that mainly infect the hepatocytes. At present, there are five …

[HTML][HTML] From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis

J Aljabban, N Danis, M Gurakar, K Khorfan… - Hepatology …, 2020 - ncbi.nlm.nih.gov
Results HCV cirrhosis analysis demonstrated LPS/IL-1 mediated inhibition of RXR function,
LXR/RXR activation, sirtuin signaling, IL-10 signaling and hepatic fibrosis/stellate cell …